HRSA/Ryan White @ the National Summit on HCV/HIV

HRSA/Ryan White @ the National Summit on HCV/HIV

Monday, June 15, 2015
TARGET Center

National Summit LogoHRSA and the Ryan White HIV/AIDS Program were all over the June 4-6, 2015 National Summit of HCV and HIV Diagnosis, Prevention and Access to Care.

The conference, convened by the Forum for Collaborative HIV Research, featured a plenary presentation by Dr. Laura Cheever, HRSA/HAB Associate Administrator for HIV/AIDS and multiple sessions featuring HRSA and Ryan White HIV/AIDS Program presenters and programs. Here are highlights from our scan of the conference program:

See National Summit abstracts, posters and other presentations.

  • Abstract 66: 2014 Recommendations for HIV Prevention with Adults and Adolescents with HIV in the U.S.: Recommendations from CDC, HRSA, NHI and 5 Non-Governmental HIV Prevention and Care Organizations
  • Abstract 98: "In Care" Persons Living with HIV Encountered Through an Urban HIV Navigation Program: Retention Does Not Equal Suppression
  • Abstract 114: Collaborating Across States to Achieve the End of AIDS - HIV Cross-Part Care Continuum Collaborative (H4C)
  • Abstract 119: Policy Implications of the Implementation of a Health Insurance Premium Payment Program for People Living with HIV in California
  • Abstract 130: Markers of Care and Viral Suppression Among HIV+ Women Prior to Referral for Re-Engagement Services
  • Abstract 136: The Patient Centered Medical Home (PCMH): A Model for Improving Access and Engagement in Care for HIV and HCV Patients
  • Abstract 138: Implementing Hepatitis C Treatment Programs in Comprehensive HIV Clinics: The Health Resources and Services Administration (HRSA) Special Projects of National Significance (SPNS) Hepatitis C Treatment Expansion Initiative
  • Abstract 139: Leveraging Resources to Create a Comprehensive HCV Program
  • Abstract 140: Visualizing Geographic Patterns in the HIV Care Continuum in Five Major US Cities
  • Track A2. HCV and HIV Testing: Integrating Testing into Primary Care Settings
  • Abstract 5: Assessment of PCP Knowledge of HCV Screening, Recommendations, and Treatment Options
  • Abstract 41:Electronic Medical Record Flags Have a Limited Impact on Hepatitis C Virus Birth Cohort Screening in the Primary Care Setting: Results of a Multifaceted Intervention to Improve Screening
  • Abstract 57: Impact of Integrating EMR HCV Testing Prompts in a Difficult to Navigate EMR System
  • Abstract 8: Dual Routine HCV and HIV Testing as a Method to Improve Detection and Linkage to Care of HCV and HIV‐Positive Patients at a Network of Community Health Centers in Philadelphia, PA
  • Abstract 10: Changing HIV Testing Habits at Community Health Centers: Strategies and Lessons from the Field
  • Abstract 3: Normalizing the Test: Effective, High‐Quality Opt‐Out HIV Testing Program in a Community Health Center Setting
  • Abstract 12: Public Health Detailing Campaign to Implement Routine HIV Screening Among Primary Care Providers in Baltimore City
  • Abstract 7: No Patient Left Behind: A Case for Universal HCV Screening
  • Abstract 110: Low HCV Testing Uptake of the Current Birth Cohort Testing Guidelines
  • Abstract 26: Determining HC V Reactivity for Baby Boomers Screened at Community‐Based Organizations
  • Abstract 27: Evaluation of CDC Recommendation s for HCV Testing in an Urban Emergency Department
  • Abstract 28: Who Participates in Community - Based Screening for Hepatitis C Infection
  • Abstract 30: Non-Risk Based HCV Screening Among Baby Boomers in Surveillance‐Identified HIV Risk Areas
  • Abstract 39: Hepatitis C Birth‐Cohort Testing and Linkage to Care, Selected U. S. Sites, 2012‐2014
  • Abstract 90: Patient Misunderstanding of HIV and HCV Testing in an Urban Emergency Department with an Integrated Screening Program
  • Abstract 133: Increasing Hepatitis C Virus (HC V) Screening and Confirmatory Testing in a Large Integrated Health System
  • Abstract 45: Expanded Testing for Hepatitis C Virus Infection in a Public Health Department and Linkage to Care in Durham, North Carolina
  • Abstract 61: Results of a Rapid Hepatitis C Virus Screening and Diagnostic Testing Program in an Urban Emergency Department
  • Abstract 71: Prisoner Health is Community Health, The New Mexico Peer Education Project (NMPEP): Assessing the Impact and Reach of a Peer‐Led Health Education Intervention Utilizing Harm Reduction Strategies in an Incarcerated Population
  • Abstract 29: Feasibility of HCV Rapid Testing Among Probationers and Parolees in Rhode Island
  • Abstract 108: Hepatitis C Treatment Experience in the New Mexico State Prison System
  • Abstract 46: CDC‐Funded HIV Testing, HIV Positivity, Linkage, and Referral Services in Correctional Facilities in the United States
  • Abstract 104: Barriers and Strategies for Linking Inmates to Care Receiving Treatment for Hepatitis C Virus (HCV) upon Release from Prison
  • Abstract 103: The South Carolina Rural-Urban HIV Cascade of Care
  • Abstract 107: Development of an HIV Continuous Quality Improvement Tool to Monitor HIV Testing, Results and Linkage to Care within a Large Medical Center
  • Abstract 109: Improving the HCV Care Cascade: Year 1 Results from a Dynamic, Integrated Linkage to Care Navigation Model
  • Abstract 123: The New York City Public Health Approach to Hepatitis C
  • Abstract 54: Advocacy & Policy Action Supporting the Elimination of HCV in the United States
  • Abstract 94: Advocacy & Policy Action Supporting the Elimination of HCV in the United States
  • Abstract 100: Creating a Hepatitis C Navigation and Linkage‐to‐Care Program
  • Abstract 106: Engaging High‐Risk Persons with Hepatitis C in Care and Treatment through Community‐Based Care Coordination: Check Hep C Year 2
  • Abstract 113: How to Embed a Hepatitis C Treatment Program into an Existing Urban Community Clinic
  • Abstract 122: The HIV Care Collaborative: Implementing Health System Navigation as a Linkage and Retention Strategy in Public Health Settings
  • Abstract 125Opportunities for Screening, Care and Treatment for HCV in a Community Health Clinic through Primary Care
  • Abstract 134: Successful Model for Providing Hepatitis C Virus Screening and Treatment at a Federally Qualified Health Center in New Orleans
  • Abstract 5: Assessment of PCP Knowledge of HCV Screening, Recommendations, and Treatment Options
  • Abstract 95: Utilizing Electronic Laboratory Reporting Data to Assess the Burden of Hepatitis C in Arizona
  • Abstract 79: Geographic Epidemiology of Hepatocellular Carcinoma and Viral Hepatitis in New York City
  • Abstract 118: Reasons New York City Patients are Not Prescribed Hepatitis C Treatment
  • Abstract 105: Hepatitis C Virus (HCV) Treatment Outcomes in the Primary Care Setting
  • Abstract 137: Efficient, Centeralized Portal Access to HIV Medication Significantly Improves Biologic Outcomes for the Uninsured
  • Abstract 132: Retained and Poorly Retained Patients with HIV had Similar Total Costs in the First Two Years of Diagnosis
  • Abstract 119: Policy Implications of the Implementation of a Health Insurance Premium Payment Program for People Living with HIV in California
  • Abstract 140LB: Examining HCV Treatment Access
  • Abstract 124: How a Medicaid HIV Special Needs Managed Care Plan in NYC Achieved Cost Savings and Successful Clinical Outcomes
  • Abstract 81: Health Care Costs and Resource Use Associated with Sequelae and Comorbidities Among Patients with Chronic HCV
  • The Ryan White HIV/AIDS Program in the Age of Health Care Reform
  • Abstract 31: Prevalence of Hepatitis C Virus Infection in an Unselected Midwestern Emergency Department Population
  • Abstract 19: Current State of HIV Testing in a Comprehensive Cancer Center
  • Abstract 43: Self‐Requests for ED‐Based HIV Testing Yield Higher Positivity Rates than Risk‐Based Targeting
  • Abstract 59: Billing and Reimbursement as a Model for Sustainable Emergency Department HIV Screening? Report from the 2012 National Emergency Department HIV Testing Consortium Meeting
  • Abstract 50: Challenges to Enhanced Reliance on Third Party Reimbursement for HIV Testing in the District of Columbia
  • Abstract 40: Assessing Billing Practices for Routine HIV and HCV Tests in Philadelphia’s Clinical Settings
  • Abstract 13: Implementing and Sustaining Routine HIV Screening of Adolescents in Pediatric Emergency Departments
  • Abstract 38: As Routine As It Gets: Five Years of Routine HIV Screening in two Houston Emergency Centers
  • Abstract 18:Implementing and Tracking Progress toward Routine HIV Testing in a Large Hospital Outpatient Department
  • Abstract 52: Expansion of HIV Testing - THe 2014 European HIV Testing Week
  • Abstract 6: Project IMPACT: HIV and HCV Testing in the Orleans Parish Municipal Court and at a Syringe Access
  • Abstract 126: Barriers to Engagement in HCV Treatment after Community‐Based Screening in Oakland, CA
  • Abstract 117: Incorporating a Co‐Located Infectious Disease Clinic in Syringe Access Services
  • Abstract 102: Acceptability of Extended‐Release Naltrexone as a Conduit to Care for HIV+ Criminal Justice Populations
  • Abstract 70: Application of the Information‐ Motivation Behavioral Skills Model to HIV and HCV Risk and Needle Sharing Behaviors Among Persons who Inject Drugs
  • Abstract 44:Scaling Up HIV Testing in an Academic Emergency Department: An Integrated Testing Model with Both Fourth‐Generation Testing and Point‐of‐Care (POC) Testing
  • Abstract 36: Laboratory Driven Expedited HIV Screening and Confirmation at an Urban Emergency Department in Washington, DC
  • Abstract 80:Acute HIV Infection and Sero‐Conversion: Why You Should Screen for HIV and Why You Should Keep Doing It
  • Abstract 34: Identifying Acute HIV Infections in the Emergency Room: Benefits of Fourth Generation HIV Testing
  • Abstract 97: The Impact of 4th Generation HIV Testing in Tennessee: Identification and Linkage to Care of Individuals with Acute HIV Infection
  • Abstract 93: Routine HIV Screening, Acute Infection Diagnosis, and Partner Engagement: The Experience of a Safety Net Provider in Chicago
  • Abstract 53: Performance of Determine Combo and other Point‐of‐Care HIV Tests Among Seattle MSM
  • Abstract 58: Evaluation of the BioPlex® 2200 HIV Ag‐Ab assay*: A Next Generation Fully Automated Screening Method Providing Discreet Detection of HIV‐1 p24 Antigen, HIV‐1 Antibody and HIV‐2 Antibody * Pending FDA approval
  • Abstract 97LB: Evaluation of the Xpert® HIV-1 Qual Assay and Xpert® HIV-1 Viral Load Assay
  • Abstract 129: Restructuring Linkage‐To‐Care: Finding a Model That Works For You and Your Clients
  • Abstract 101: Implementation of an HCV Linkage to Cure Program at an Urban Safety Net Hospital
  • Abstract 127: Increasing access to HIV Care through Institutional Policy in the Acute Care Setting
  • Abstract 135:Patient Experience and Satisfaction with the Use of HIV Telemedicine Services among HIV+ Individuals Living Throughout Rural Alabama
  • Abstract 121:Enhancing Access to Care for African and Caribbean Immigrants with HIV Infection